Steering Committee of the Physicians‘ Health Study Research Group Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med.321, 1989, 129-35.
Ridker, PM. et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med.352, 2005, 1293-304.
Antithrombotic Trialists’(ATT) Collaboration.: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet.373, 2009, 1849-60.
Ogawa, H. et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA.300(18), 2008, 2134-41.